FOLLOW-UP VESSEL WALL MR IMAGING TO EXPLORE SEX-DIFFERENCES OF INTRACRANIAL ARTERIAL WALL CHANGES AND INTRACRANIAL ATHEROSCLEROTIC PLAQUE TREATMENT EFFICACY
Recruiting
99 years or below
All
1 Location
Brief description of study
Mortality related to cardiovascular disease in the US is improving. Yet the rate of decline is less for women than for men. Women's health is unique due to the varying reproductive stages, and differences are further heightened by sex-specific molecular and cellular characteristics of the heart and vasculature. These biophysiological distinctions may help explain sex disparities in risk factor burden and outcomes after a stroke. While women have some unique risk factors, the predominant risk factors for stroke, such as hypertension and hyperlipidemia, are similar between the sexes. However, the frequency of each risk factor varies resulting in differing population attributable risks. Effective screening and early management of these modifiable risk factors will have the greatest impact to stroke prevention. The same risk factors for cardiovascular disease also underlie the development of intracranial atherosclerotic disease (ICAD), a leading cause of stroke. Yet surprisingly, the development and progression of ICAD has not been explored in women despite the intimate association with stroke. High-resolution vessel wall MR imaging (VWI) permits visualization of vessel wall changes and may potentially serve as a noninvasive screening test for populations of women for early ICAD detection. We propose a study to prospectively evaluate women and men with stroke using VWI to estimate the prevalence of vessel wall abnormalities leading to stroke. Early detection of vessel wall changes in correlation with modifiable risk factors will help us identify opportunities for early prevention of stroke in women. Additionally, longitudinal imaging data and statin non-adherence questionnaires will provide data to evaluate the efficiency of stroke treatment post intervention and identify reasons for non-adherence.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: neurology
-
Age: 99 years or below
-
Gender: All
Updated on
19 Feb 2024.
Study ID: 833594
Find a site
,
Your Information has been sent successfully.
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up
Send a message
Enter your contact details to connect with study team
Primary Contact
Message For Non Enrolling By Invitation Trial
Select a study center that’s convenient for you, and get in touch with the study team.
Please choose between Voice or SMS based delivery of verification code
or